145 related articles for article (PubMed ID: 10451666)
1. HIV prevalence at reception into Australian prisons, 1991-1997.
McDonald AM; Ryan JW; Brown PR; Manners CJ; Falconer AD; Kinnear RC; Harvey WJ; Hearne PR; Banaszczyk M; Kaldor JM
Med J Aust; 1999 Jul; 171(1):18-21. PubMed ID: 10451666
[TBL] [Abstract][Full Text] [Related]
2. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010.
Reekie JM; Levy MH; Richards AH; Wake CJ; Siddall DA; Beasley HM; Kumar S; Butler TG
Med J Aust; 2014 Mar; 200(5):277-80. PubMed ID: 24641153
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey.
Long J; Allwright S; Barry J; Reynolds SR; Thornton L; Bradley F; Parry JV
BMJ; 2001 Nov; 323(7323):1209-13. PubMed ID: 11719410
[TBL] [Abstract][Full Text] [Related]
4. Spread of bloodborne viruses among Australian prison entrants.
Crofts N; Stewart T; Hearne P; Ping XY; Breshkin AM; Locarnini SA
BMJ; 1995 Feb; 310(6975):285-8. PubMed ID: 7866168
[TBL] [Abstract][Full Text] [Related]
5. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of and risk factors for Human Immunodeficiency Virus (HIV) infection in entrants and residents of an Ethiopian prison.
Sahle ET; Amogne W; Manyazewal T; Blumenthal J; Jain S; Sun S; Young J; Ellorin E; Woldeamanuel H; Teferra L; Feleke B; Vandenberg O; Rey Z; Briggs-Hagen M; Haubrich R; McCutchan JA
PLoS One; 2023; 18(2):e0271666. PubMed ID: 36758059
[TBL] [Abstract][Full Text] [Related]
7. Trends in hepatitis B prevalence and associated risk factors among Indigenous and non-Indigenous prison entrants in Australia, 2004 to 2013.
Coles T; Simpson P; Saulo D; Kaldor J; Richards A; Levy M; Wake C; Siddall DA; Harrod ME; Kariminia A; Butler T
Aust N Z J Public Health; 2019 Jun; 43(3):236-240. PubMed ID: 30690821
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey.
Wali A; Khan D; Safdar N; Shawani Z; Fatima R; Yaqoob A; Qadir A; Ahmed S; Rashid H; Ahmed B; Khan S
BMC Public Health; 2019 Dec; 19(1):1631. PubMed ID: 31801496
[TBL] [Abstract][Full Text] [Related]
9. HIV transmission in a prison system in an Australian State.
Dolan KA; Wodak A
Med J Aust; 1999 Jul; 171(1):14-7. PubMed ID: 10451665
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B and C in New South Wales prisons: prevalence and risk factors.
Butler TG; Dolan KA; Ferson MJ; McGuinness LM; Brown PR; Robertson PW
Med J Aust; 1997 Feb; 166(3):127-30. PubMed ID: 9059433
[TBL] [Abstract][Full Text] [Related]
11. People who inject drugs in prison: HIV prevalence, transmission and prevention.
Dolan K; Moazen B; Noori A; Rahimzadeh S; Farzadfar F; Hariga F
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S12-5. PubMed ID: 25727258
[TBL] [Abstract][Full Text] [Related]
12. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.
Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J;
J Viral Hepat; 2017 Sep; 24(9):733-741. PubMed ID: 28256027
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER; Bi P; Ryan P
Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HIV infection in provincial prisons in British Columbia.
Rothon DA; Mathias RG; Schechter MT
CMAJ; 1994 Sep; 151(6):781-7. PubMed ID: 8087754
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.
Allwright S; Bradley F; Long J; Barry J; Thornton L; Parry JV
BMJ; 2000 Jul; 321(7253):78-82. PubMed ID: 10884256
[TBL] [Abstract][Full Text] [Related]
16. HIV testing and counselling in Estonian prisons, 2012 to 2013: aims, processes and impacts.
Kivimets K; Uuskula A
Euro Surveill; 2014 Nov; 19(47):20970. PubMed ID: 25443037
[TBL] [Abstract][Full Text] [Related]
17. Evidence of HIV transmission in an Australian prison.
Dolan K; Hall W; Wodak A; Gaughwin M
Med J Aust; 1994 Jun; 160(11):734. PubMed ID: 8202021
[No Abstract] [Full Text] [Related]
18. Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework.
Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C
Addiction; 2023 Jun; 118(6):1153-1160. PubMed ID: 36683132
[TBL] [Abstract][Full Text] [Related]
19. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
20. Drug injection and HIV prevalence in inmates of Glenochil prison.
Gore SM; Bird AG; Burns SM; Goldberg DJ; Ross AJ; Macgregor J
BMJ; 1995 Feb; 310(6975):293-6. PubMed ID: 7866170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
